Scholars Central

Mini reviewPublished 8 Oct 2021

Diagnostic Metagenomics as Diagnostic Tools in Infectious Diseases

Authors: Kendall Kling, Teresa Zembower, Chao Qi

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Treatment of infections with culture-negative results represents a challenge to clinicians. Culture-independent broad-range nucleic acid sequencing methodologies capable of identifying pathogens at the genomic level have emerged as powerful diagnostic tools. While traditional Sanger sequencing only allows a single target detection, Metagenomic Next-Generation Sequencing (mNGS) enables the detection of all types of organisms, including viruses, bacteria, fungi, and parasites, in a single-assay. Its potential for broad-range pathogen detection with high sensitivity offers a diagnostic opportunity for patients with a widerange of differential diagnoses. Currently there is no FDA-approved metagenomic diagnostic test. Clinical laboratories face many obstacles in implementing mNGS assays. Streaming sequencing process, developing and validating a comprehensive database, and standardizing the bioinformatics pipelines for data analysis are among the challenges to be addressed. When the technology becomes more readily available in clinical laboratories, its value for improving infectious diseases diagnosis will be realized.

Subjects

Microbiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives of Clinical Microbiology
  • SubjectMicrobiology
  • BylineArticles whose byline prints “Kendall Kling”
  • BylineArticles whose byline prints “Teresa Zembower”
  • BylineArticles whose byline prints “Chao Qi”